- Home
- RARE vs CAKE Comparison
RARE vs CAKE Comparison
Compare RARE & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- CAKE
- Stock Information
- Founded
- RARE 2010
- CAKE 1972
- Country
- RARE United States
- CAKE United States
- Employees
- RARE N/A
- CAKE N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- CAKE Restaurants
- Sector
- RARE Health Care
- CAKE Consumer Discretionary
- Exchange
- RARE Nasdaq
- CAKE Nasdaq
- Market Cap
- RARE 3.1B
- CAKE 2.7B
- IPO Year
- RARE 2014
- CAKE 1992
- Fundamental
- Price
- RARE $33.28
- CAKE $56.48
- Analyst Decision
- RARE Strong Buy
- CAKE Hold
- Analyst Count
- RARE 13
- CAKE 14
- Target Price
- RARE $87.69
- CAKE $60.14
- AVG Volume (30 Days)
- RARE 1.5M
- CAKE 1.1M
- Earning Date
- RARE 11-03-2025
- CAKE 10-28-2025
- Dividend Yield
- RARE N/A
- CAKE 1.91%
- EPS Growth
- RARE N/A
- CAKE 35.29
- EPS
- RARE N/A
- CAKE 3.24
- Revenue
- RARE $610,159,000.00
- CAKE $3,669,456,000.00
- Revenue This Year
- RARE $19.72
- CAKE $7.24
- Revenue Next Year
- RARE $23.29
- CAKE $6.07
- P/E Ratio
- RARE N/A
- CAKE $17.49
- Revenue Growth
- RARE 26.77
- CAKE 4.77
- 52 Week Low
- RARE $25.81
- CAKE $40.72
- 52 Week High
- RARE $56.38
- CAKE $69.70
- Technical
- Relative Strength Index (RSI)
- RARE 58.42
- CAKE 56.31
- Support Level
- RARE $32.40
- CAKE $53.71
- Resistance Level
- RARE $34.78
- CAKE $55.28
- Average True Range (ATR)
- RARE 1.26
- CAKE 1.29
- MACD
- RARE 0.27
- CAKE 0.47
- Stochastic Oscillator
- RARE 71.21
- CAKE 94.08
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.